Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

HealthCall:Brief Intervention to Reduce Non-injecting Drug Use in HIV Primary Care Clinics

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2014 by Research Foundation for Mental Hygiene, Inc.
Sponsor:
Information provided by (Responsible Party):
Efrat Aharonovich, Research Foundation for Mental Hygiene, Inc.
ClinicalTrials.gov Identifier:
NCT01312181
First received: March 9, 2011
Last updated: September 12, 2014
Last verified: September 2014

March 9, 2011
September 12, 2014
June 2011
June 2015   (final data collection date for primary outcome measure)
The primary outcome variable is drug use, assessed at baseline and repeatedly during follow-up so that change can be analyzed. [ Time Frame: Assessed at baseline, 30 and 60 days, 3,6 and 12 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01312181 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
HealthCall:Brief Intervention to Reduce Non-injecting Drug Use in HIV Primary Care Clinics
HealthCall: Brief Intervention to Reduce Drug Use in HIV Primary Care

Among HIV-infected individuals, non-injection drug use (NIDU) is associated with poor HIV medication adherence, greater HIV/AIDS risk behaviors, and increasing non-AIDS mortality. Thus reducing NIDU among HIV infected individuals is critical to their survival and to limiting the spread of HIV. We propose to study the efficacy of a technologically enhanced brief intervention (HealthCall) to reduce NIDU in HIV primary care patients that demands little from busy medical staff and is well accepted by patients. In a 3-arm randomized clinical trial will test the efficacy of (a) Motivational Interviewing (MI)+HealthCall; (b) MI-only; and (c) a control condition (advice + DVD HIV health education) in reducing NIDU.

Not Provided
Interventional
Phase 1
Phase 2
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Mental and Behavioral Disorders Due to Multiple Drug Use and Use of Other Psychoactive Substances: Harmful Use
  • Behavioral: HealthCall and Motivational Interviewing
    A basic behavioral intervention used in the 3 arms including the Motivational Interview (MI), the two components of HealthCall (IVR, personalized feedback) and the advice+DVD educational control arm.
  • Behavioral: Motivational Interviewing (MI)
    A basic behavioral intervention used in the 3 arms including the Motivational Interview (MI), the two components of HealthCall (IVR, personalized feedback) and the advice+DVD educational control arm.
  • Behavioral: HIV/AIDS health education
    A basic behavioral intervention used in the 3 arms including the Motivational Interview (MI), the two components of HealthCall (IVR, personalized feedback) and the advice+DVD educational control arm.
  • Active Comparator: HealthCall +Motivational Interviewing
    Patients access HealthCall by calling a toll-free number and putting a four-digit Personal Identification Number (PIN). The HealthCall system will then ask a short script of pre-recorded questions in English or Spanish, on substance use and other variables (e.g., medication adherence, unprotected sex, feeling of physical well-being, stress, etc).
    Intervention: Behavioral: HealthCall and Motivational Interviewing
  • Active Comparator: Motivational Interviewing (MI)
    The MI session focuses on reduce ambivalence and increase motivation to reduce non-injection drug use (NIDU), gain a commitment to change, if possible, and ultimately to reduce or eliminate NIDU. The intervention includes: a) identifying pros and cons of using and stopping; b) exploring ambivalence about stopping NIDU; c) eliciting change talk
    Intervention: Behavioral: Motivational Interviewing (MI)
  • Placebo Comparator: HIV/AIDS health education - DVD control
    HIV/AIDS health education - DVD control. The purpose of this condition is to control for clinical attention associated with Motivational Interviewing (MI)participation, and to provide an analogue of standard care, i.e. brief advice but no other intervention.
    Intervention: Behavioral: HIV/AIDS health education

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
390
December 2015
June 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • All research volunteers will be 18 and older and HIV positive. We will include participants whose primary drug is non-injection use of cocaine, opioids including heroin, or methamphetamines and current use in the past 30 days > 4 days. Participants will need to complete a medically supervised detoxification if such detoxification is required.

Exclusion Criteria:

  • Excluded are research volunteers for whom participation would not be clinically appropriate, who clearly could not participate. Psychotic, suicidal or homicidal patients require clinical management that is too intensive for this study, and we have no evidence that MI+HealthCall would be effective among injection drug users. Leaving New York precludes follow-up. Gross psychomotor/cognitive impairments that may hinder patients' HealthCall use. Hearing and severe vision impairments that preclude telephone use precludes randomization to MI+HealthCall.
Both
18 Years and older
No
Contact: Efrat Aharonovich, PhD ea2017@columbia.edu
United States
 
NCT01312181
R01 DA024606-01
Yes
Efrat Aharonovich, Research Foundation for Mental Hygiene, Inc.
Research Foundation for Mental Hygiene, Inc.
Not Provided
Principal Investigator: Efrat Aharonovich, PhD The New York State Psychiatric Institute and Columbia Univeristy
Research Foundation for Mental Hygiene, Inc.
September 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP